Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia
Kristin Synnestvedt, Glenn T. Furuta, Katrina M. Comerford, Nancy Louis, Jorn Karhausen, Holger K. Eltzschig, Karl R. Hansen, Linda F. Thompson, Sean P. Colgan
Kristin Synnestvedt, Glenn T. Furuta, Katrina M. Comerford, Nancy Louis, Jorn Karhausen, Holger K. Eltzschig, Karl R. Hansen, Linda F. Thompson, Sean P. Colgan
View: Text | PDF
Article

Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

  • Text
  • PDF
Abstract

Research Article

Authors

Kristin Synnestvedt, Glenn T. Furuta, Katrina M. Comerford, Nancy Louis, Jorn Karhausen, Holger K. Eltzschig, Karl R. Hansen, Linda F. Thompson, Sean P. Colgan

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Functional increase in CD73 surface activity by hypoxia. (a) Epithelial ...
Functional increase in CD73 surface activity by hypoxia. (a) Epithelial monolayers were exposed to indicated periods of hypoxia and washed, and surface CD73 activity was determined by HPLC analysis of E-AMP conversion to E-ADO (black bars). To determine specificity, a similar analysis was performed in the presence of the CD73 inhibitor APCP (white bars). Data are derived from five to seven monolayers in each condition, and results are expressed as mean percent E-AMP conversion ± SEM. The inset is a representative HPLC tracing demonstrating peak resolution of E-AMP and E-ADO. mAu, milli-absorbance unit. (b) Confluent T84 monolayers were subjected to hypoxia for 24 hours and treated with 2 mM EDTA for 5 minutes, followed by incubation in cell culture media with normo-calcium in the presence of indicated concentrations of 5′-AMP. TER was monitored over time, and the results shown represent the percent recovery of TER over 2 hours relative to no 5′-AMP. Also shown are plots of monolayers coincubated with the adenosine A2B receptor antagonist alloxazine (allox; 10 μM). Data are mean ± SEM from three separate experiments. *P < 0.025 compared with normoxia.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts